Hemodynamic, Laboratory, and Clinical Outcomes of Hemoadsorption Therapy
Recruiting
Observational Study
Hemoadsorption
Vasopressor Therapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Pest County Flór Ferenc Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This single-center retrospective observational cohort study aims to evaluate the clinical, hemodynamic, and laboratory effects of adjunctive hemoadsorption therapy in critically ill adult patients treated in the Intensive Care Unit of Flór Ferenc Hospital, Hungary, between January 1, 2020, and May 31, 2026. Patients who received CytoSorb® or Efferon LPS® hemoadsorption therapy will be included.
T…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \>18 years;
* CytoSorb or Efferon LPS hemoadsorption treatment,
* with available relevant pre- and post-treatment clinical and laboratory data
Exclusion Criteria:
* age under 18 years
* missing key demographic or outcome data;
* unknown treatment type or timing;
* data unava…
Contacts